GO
Loading...

Johnson & Johnson

More

  • That has focused attention on other AbbVie drugs with blockbuster potential, including Viekira Pak, a new hepatitis C medication approved in the U.S. in December. But U.S. sales of $138 million in the first quarter came in below expectations of $215 million, on average, according to survey figures cited by analyst Robyn Karnauskas of Deutsche Bank.

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 6:13 PM ET

    Baxter International Inc. rose$. 33 or. 5 percent, to $70.38. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $66.60. Hospira rose$. 04 or percent, to $87.80.

  • Final Glance: Medical Devices companies Wednesday, 22 Apr 2015 | 6:13 PM ET

    Baxter International Inc. rose$. 33 or. 5 percent, to $70.38. Boston Scientific Corp. rose$. 10 or. 5 percent, to $18.41. Johnson& Johnson rose$. 13 or. 1 percent, to $100.43.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 1:39 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $69.93. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $66.60. Eli Lilly& Co. fell$. 02 or percent, to $72.19.

  • Midday Glance: Medical Devices companies Wednesday, 22 Apr 2015 | 1:39 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $69.93. Boston Scientific Corp. rose$. 04 or. 2 percent, to $18.35. Johnson& Johnson rose$. 14 or. 1 percent, to $100.44.

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 10:25 AM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $66.70. Eli Lilly& Co. rose$. 09 or. 1 percent, to $72.30.

  • Early Glance: Medical Devices companies Wednesday, 22 Apr 2015 | 10:25 AM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $70.16. Boston Scientific Corp. rose$. 11 or. 6 percent, to $18.42. Johnson& Johnson rose$. 03 or percent, to $100.33.

  • Final Glance: Pharmaceuticals companies Tuesday, 21 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $70.05. Bristol-Myers Squibb Co. rose$. 95 or 1.4 percent, to $66.81. Eli Lilly& Co. fell$. 20 or. 3 percent, to $72.21.

  • Final Glance: Medical Devices companies Tuesday, 21 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $70.05. Boston Scientific Corp. rose$. 12 or. 7 percent, to $18.31. Johnson& Johnson rose$. 09 or. 1 percent, to $100.30.

  • Midday Glance: Medical Devices companies Tuesday, 21 Apr 2015 | 1:45 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $70.05. Boston Scientific Corp. rose$. 06 or. 3 percent, to $18.25. Johnson& Johnson rose$. 23 or. 2 percent, to $100.44.

  • Midday Glance: Pharmaceuticals companies Tuesday, 21 Apr 2015 | 1:45 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $70.05. Bristol-Myers Squibb Co. rose$. 82 or 1.2 percent, to $66.68. Hospira fell$. 03 or percent, to $87.81.

  • Early Glance: Pharmaceuticals companies Tuesday, 21 Apr 2015 | 10:52 AM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $70.00. Bristol-Myers Squibb Co. rose$. 67 or 1.0 percent, to $66.53. Eli Lilly& Co. rose$. 27 or. 4 percent, to $72.68.

  • Early Glance: Medical Devices companies Tuesday, 21 Apr 2015 | 10:52 AM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $70.00. Boston Scientific Corp. rose$. 02 or. 1 percent, to $18.21. Johnson& Johnson rose$. 64 or. 6 percent, to $100.85.

  • *Global nutraceutical market seen at $280 bln by 2018. LONDON, April 21- A boom in "nutraceuticals"- food and drinks with potential health benefits- is paving the way for a rush of deals, as food and drug companies compete to dominate a market expected to be worth $280 billion by 2018.. "The space is ripe for M&A and I think you are going to see more," added Jeremy Johnson,...

  • Asian stocks mostly higher as Japan exports improve Tuesday, 21 Apr 2015 | 12:31 AM ET

    TAKING IT ALL IN: "It seems the market is in a holding pattern as investors are waiting to see just how much the dollar impacts corporate earnings," said Russell Price, Ameriprise Financial's senior economist. The chemical giant also lowered its forecast for full-year profits, and its stock fell $2.15, or 3 percent, to $70.70. CLEANING UP: Kimberly-Clark jumped 4...

  • Final Glance: Medical Devices companies Monday, 20 Apr 2015 | 7:11 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $70.36. Boston Scientific Corp. fell$. 21 or 1.1 percent, to $18.19. Johnson& Johnson rose$. 63 or. 6 percent, to $100.21.

  • Final Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 7:11 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $70.36. Bristol-Myers Squibb Co. rose$. 51 or. 8 percent, to $65.86. Eli Lilly& Co. fell$. 06 or. 1 percent, to $72.41.

  • Midday Glance: Medical Devices companies Monday, 20 Apr 2015 | 1:17 PM ET

    Baxter International Inc. rose$. 56 or. 8 percent, to $70.47. Boston Scientific Corp. fell$. 17 or. 9 percent, to $18.24. Johnson& Johnson rose$. 90 or. 9 percent, to $100.48.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 1:17 PM ET

    Baxter International Inc. rose$. 56 or. 8 percent, to $70.47. Bristol-Myers Squibb Co. rose$. 56 or. 9 percent, to $65.91. Eli Lilly& Co. fell$. 10 or. 1 percent, to $72.38.

  • Early Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 10:38 AM ET

    Baxter International Inc. rose$. 34 or. 5 percent, to $70.25. Bristol-Myers Squibb Co. rose$. 28 or. 4 percent, to $65.63. Eli Lilly& Co. rose$. 38 or. 5 percent, to $72.85.